PLRZ
Polyrizon Ltd. Ordinary Shares

5,584
Mkt Cap
$13.08M
Volume
2.09M
52W High
$7,200.00
52W Low
$2.88
PE Ratio
-0.23
PLRZ Fundamentals
Price
$13.10
Prev Close
$14.50
Open
$12.57
50D MA
$6.10
Beta
-1.30
Avg. Volume
43,382.10
EPS (Annual)
-$92.09
P/B
4.19
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Small Cap Stocks To Keep An Eye On - December 4th
SMX (Security Matters) Public, Spring Valley Acquisition, Direxion Daily META Bull 2X Shares, Polyrizon, and Direxion Daily TSLA Bear 1X Shares are the five Small Cap stocks to watch today, according...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Top Biotech Stocks To Consider - December 4th
Danaher, Polyrizon, Vertex Pharmaceuticals, Medpace, Abivax, Capricor Therapeutics, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech...
MarketBeat·2d ago
News Placeholder
Polyrizon Stock Skyrockets After New Data Shows Naloxone Gel Outperforms Marketed Spray
Polyrizon stock is up on new data showing its naloxone hydrogel formulation has stronger and longer-lasting mucosal retention.read more...
Benzinga·3d ago
News Placeholder
What Sparked Polyrizon's (PLRZ) 140% After-Hours Stock Surge?
Polyrizon surged in nearly 140% after-hours trading following preclinical data showing its naloxone hydrogel outperforms a marketed spray and a key manufacturing milestone.read more...
Benzinga·4d ago
News Placeholder
Polyrizon Hits Key Breakthrough That Brings Its Nasal Spray Closer To 2026 Trials
Polyrizon jumps over 100%. The company completes major manufacturing milestone for its proprietary nasal-spray product platform.read more...
Benzinga·5d ago
News Placeholder
Why Did Polyrizon Stock Soar Pre-Market Today?
Polyrizon successfully scaled its production process from small laboratory batches to larger, controlled manufacturing runs, validating the key parameters of its PL-14 formulation.
Stocktwits·5d ago
News Placeholder
Polyrizon, Pheton, AirSculpt: Top 3 Healthcare Stocks With Soaring Weekly Retail Interest
A trio of small-cap healthcare stocks caught the attention of retail investors last week, posting sharp jumps in follower growth on Stocktwits.
Stocktwits·7mo ago
News Placeholder
Polyrizon's Retail Following Booms As Biotech Stock Triples On Manufacturing Deal For Allergy Blocker Trial
This collaboration will supply clinical trial material for Polyrizon’s experimental allergy blocker, PL-14, which is set to enter clinical trials in 2025.
Stocktwits·1y ago

Latest PLRZ News

View

Advertisement|Remove ads.

Advertisement|Remove ads.